IN.gov - Skip Navigation

Note: This message is displayed if (1) your browser is not standards-compliant or (2) you have you disabled CSS. Read our Policies for more information.

Indiana Professional Licensing Agency

INSPECT > About INSPECT & Contact Info About INSPECT

An INSPECT report summarizes the controlled substances a patient has been prescribed, the practitioner who prescribed them and the dispensing pharmacy where the patient obtained them.

Contact Us

Professional Licensing Agency
Attn: INSPECT Program
402 W. Washington Street, Room W072
Indianapolis, Indiana 46204
Phone Number: 317-234-4458
Fax: 317-232-2115

E-mail: inspect@pla.in.gov

Office Hours:  8:00 a.m. to 4:30 p.m. Monday through Friday

INSPECT Purpose & Goals

INSPECT was designed to serve as a tool to address the problem of prescription drug abuse and diversion in Indiana. By compiling controlled substance information into an online database (PMP Webcenter) INSPECT performs two critical functions:

  1. Maintain a warehouse of patient information for health care professionals.
  2. Provide an important investigative tool for law enforcement.

INSPECT does not seek to limit the ability of doctors to perform their jobs effectively, nor does it intend to violate individual privacy or patient rights. Various security measures have been put in place to prevent abuse and ensure the confidentiality of patient medical records and other privileged information.

INSPECT History

The Indiana General Assembly passed legislation in the mid-1990s that required the collection of controlled substance data through the Central Repository for Controlled Substances Data.

At its inception, Indiana’s Prescription Drug Monitoring program required licensed pharmacies in Indiana to report on dispensed schedule II controlled substances. In early 2004, grant funding and an act of the legislature helped create INSPECT in its present form, expanding reporting requirements to include schedule II through V controlled substances.

INSPECT continues to be partially funded through the Harold Rogers grant program, which provides similar funding in other states. Additional funding for INSPECT is provided at the state level, derived from a percentage of controlled substance licensing fees.

All data collection and maintenance activities for INSPECT are handled in-house. The data repository is accessible only to registered users and available only through a secure Web site maintained by program staff.